Equities

Joincare Pharmaceutical Group Industry Co Ltd

Joincare Pharmaceutical Group Industry Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)9.53
  • Today's Change-2.25 / -19.10%
  • Shares traded9.91m
  • 1 Year change-22.39%
  • Beta1.1153
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Joincare Pharmaceutical Group Industry Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals and healthcare products. The Company's products include chemical materials and intermediates, chemical agents, health products, traditional Chinese medicines, diagnostic reagents and equipment. The Company is also engaged in electricity business. The Company distributes its products within domestic market and to overseas markets.

  • Revenue in CNY (TTM)15.89bn
  • Net income in CNY1.47bn
  • Incorporated1992
  • Employees14.37k
  • Location
    Joincare Pharmaceutical Group Industry Co LtdJoincare Pharmaceutical Group PlazaNo.17 Langshan Road, North SectionHigh-Tech Zone, Nanshan DistrictSHENZHEN 518057ChinaCHN
  • Phone+86 75 586252656
  • Fax+86 75 586252165
  • Websitehttps://www.joincare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Liaoning Cheng Da Co Ltd11.29bn346.30m18.17bn3.36k52.390.6151--1.610.22680.22687.4219.310.23715.285.773,365,262.000.23223.590.32975.2113.9014.150.97939.890.9129--0.283115.93-25.97-10.97-80.95-21.267.04--
Shandong Buchang Pharmaceuticals Co Ltd11.78bn-293.31m18.85bn8.31k--1.69--1.60-0.2619-0.261910.7610.090.57771.089.781,416,955.00-2.263.26-3.134.7258.2574.71-3.924.850.50700.16020.2675121.01-11.41-0.6219120.85-29.93-16.56-36.72
Joincare Pharmaceutical Group Ind. Co.15.89bn1.47bn22.08bn14.37k14.711.52--1.390.80060.80068.657.730.44192.275.661,106,434.008.458.4617.5818.8461.9662.7219.1317.001.94--0.224128.86-2.908.24-3.9915.5811.532.38
Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd8.04bn932.37m22.54bn4.62k28.104.07--2.801.211.2110.428.340.75672.643.241,740,681.008.668.9613.5512.8045.8040.8211.4410.671.31--0.204756.93-0.32665.2814.4911.93-4.3342.22
Tasly Pharmaceutical Group Co Ltd8.57bn880.84m22.62bn9.22k25.761.78--2.640.58780.58785.738.510.49641.738.48928,676.304.895.476.147.2565.2848.429.868.942.193.890.176650.990.4236-13.57505.34-7.07-3.031.92
China Resources Dubl-Crne Phrmctl Co Ltd11.22bn1.65bn23.11bn12.27k13.842.27--2.061.611.6110.939.810.71063.046.08914,865.0010.548.4014.7011.0856.3458.1914.8311.981.26--0.063335.916.204.4412.966.6021.46-1.63
Nanjing King-Frind Bchmcl Phrmctcl C Ltd3.88bn-422.97m23.52bn1.45k--3.75--6.07-0.3269-0.32692.433.880.37740.50124.352,672,280.00-4.128.97-5.7613.1541.0045.59-10.9120.121.51-2.960.26926.335.8918.25-117.37--38.3213.75
Zhejiang Huahai Pharmaceutical Co., Ltd.9.35bn1.14bn26.30bn8.22k23.072.99--2.810.77720.77726.345.990.49221.023.511,137,186.006.015.678.378.0761.9760.5212.2111.610.79196.250.454133.550.519910.28-28.8850.517.21--
Shanghai Junshi Biosciences Co Ltd1.79bn-1.80bn26.31bn2.53k--4.93--14.72-1.83-1.831.816.260.15930.84064.29695,986.10-17.55-18.87-21.98-23.1169.0769.13-110.18-88.411.75-67.730.3065--3.38248.394.38--8.36--
Data as of Sep 13 2024. Currency figures normalised to Joincare Pharmaceutical Group Industry Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

5.95%Per cent of shares held by top holders
HolderShares% Held
China Southern Asset Management Co., Ltd.as of 10 Sep 202417.16m0.89%
Perseverance Asset Management LPas of 10 Sep 202414.36m0.75%
China Foreign Economy & Trade Trust Co., Ltd.as of 10 Sep 202413.13m0.68%
Huaxia Life Insurance Co. Ltd. (Investment Portfolio)as of 30 Jun 202412.83m0.67%
Abu Dhabi Investment Authority (Investment Management)as of 10 Sep 202412.49m0.65%
CPIC Fund Management Co. Ltd.as of 10 Sep 202410.10m0.52%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20249.89m0.51%
Yinhua Fund Management Co., Ltd.as of 10 Sep 20249.68m0.50%
GF Fund Management Co., Ltd.as of 30 Jun 20248.52m0.44%
China Asset Management Co., Ltd.as of 30 Jun 20246.43m0.33%
More ▼
Data from 30 Jun 2024 - 01 Nov 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.